We are in a unique period of time where technology advances in all sectors can be leveraged to significantly transform healthcare. The transition from paper to digital combined with machine learning, changes the entire healthcare and life sciences landscape. Cardinal Partners’ long experience working with scientists at MIT, Stanford, Harvard, John Hopkins and Scripps Institute, provide an unfair advantage enabling us to identify promising new ideas and grow them into reality.
Engineering the flow of healthcare
By the numbers
100+
Companies Invested
$15B+
in market value
$400M
under management
25+
IPOs
30%
Consumer Sector
25%
Virtual Care
20%
Life Sciences
25%
Machine Learning/NLP/Blockchain
HOW CAN WE DELIVER MORE CARE TO MORE PEOPLE FOR LESS MONEY
— Arnie Milstein
Director, Stanford Center For Clinical Excellence Research
Venture Partner, Cardinal Partners
Investment Strategy
Understanding the complexities of the health care system is the most important step towards investment success in the sector
Disruptive Healthcare Technology-Enabled Services, Life Sciences (Biopharmaceuticals)
ENGAGEMENT
Continuous, hands-on collaboration with each portfolio company to maximize its growth and success
EFFICIENCY
Instill and sustain financial discipline and capital efficiency throughout all growth phases of each portfolio company to fully leverage returns on investment capital